VPRIV Trademark

Trademark Overview

On Thursday, September 10, 2009, a trademark application was filed for VPRIV with the United States Patent and Trademark Office. The USPTO has given the VPRIV trademark a serial number of 77823522. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, March 13, 2021. This trademark is owned by Shire Human Genetic Therapies, Inc.. The VPRIV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of Gaucher's disease
vpriv

General Information

Serial Number77823522
Word MarkVPRIV
Filing DateThursday, September 10, 2009
Status800 - REGISTERED AND RENEWED
Status DateSaturday, March 13, 2021
Registration Number3815761
Registration DateTuesday, July 6, 2010
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 2, 2010

Trademark Statements

Indication of Colors claimedThe color(s) purple, blue, pink and green is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the letters "VPRIV" shown in purple beneath a horizontal series of five circular shapes diminishing in size from left to right, namely, a solid blue circular shape shown concentrically within a blue outer circle, followed by solid circular shapes shown in pink, green, pink and blue, respectively.
Goods and ServicesPharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of Gaucher's disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 14, 2009
Primary Code005
First Use Anywhere DateSaturday, February 27, 2010
First Use In Commerce DateSaturday, February 27, 2010

Trademark Owner History

Party NameShire Human Genetic Therapies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameShire Human Genetic Therapies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameShire Human Genetic Therapies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Saturday, March 13, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, March 13, 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, March 13, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, March 13, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 3, 2020TEAS SECTION 8 & 9 RECEIVED
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, July 6, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, August 2, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, August 2, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, August 2, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, May 22, 2016TEAS SECTION 8 & 15 RECEIVED
Thursday, June 30, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 30, 2011TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 6, 2010REGISTERED-PRINCIPAL REGISTER
Wednesday, June 2, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 1, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, June 1, 2010ASSIGNED TO LIE
Wednesday, May 19, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 18, 2010STATEMENT OF USE PROCESSING COMPLETE
Friday, April 30, 2010USE AMENDMENT FILED
Tuesday, May 18, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 30, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, April 27, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 2, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 2, 2010PUBLISHED FOR OPPOSITION
Tuesday, December 29, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 29, 2009ASSIGNED TO LIE
Wednesday, December 9, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 9, 2009ASSIGNED TO EXAMINER
Tuesday, September 15, 2009NOTICE OF DESIGN SEARCH CODE MAILED
Monday, September 14, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 14, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

vpriv pharmaceutical treatment preparations disease gaucher enzyme deficiencies